Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEB, formerly known as the Corporate Executive Board, was a leading best-practice insight and technology company that provided products and services to help business leaders transform their organizations. The company offered research, data, and advisory services across various corporate functions, including HR, Finance, IT, and Sales, with a significant dedicated practice for the healthcare and life sciences industries. CEB was well-regarded for its subscription-based model that provided executives with access to proprietary benchmarking data and proven management methodologies. In 2017, CEB was acquired by Gartner, a global research and advisory firm, for approximately $2.6 billion. This acquisition integrated CEB's best-practice research with Gartner's technology-focused insights to serve a broader range of corporate functions. Today, CEB's legacy services are fully integrated into Gartner's global offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Corporate Executive Board.